International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-2 doi: 10.5281/zenodo.13368573
Original Article
Evaluation Of Determinants Related To Medication Non-Adherence In Emergency Medicine Patients: A Prospective Observational Study
 ,
 ,
 ,
 ,
Published
April 28, 2024
Abstract

Background: With the escalating use of medications, there is a corresponding rise in non-adherence, posing a significant public health challenge. Medication adherence is crucial for treatment efficacy and it reflects the alignment of an individual's behaviour with medical advice. Thus, a study was devised to assess the prevalence of non-adherence-related medical emergency admissions, evaluate adherence frequency, identify implicated drug classes, and analyze underlying causes.

Methodology: The study was conducted over 12 months. This observational, prospective, uni-centric study enrolled patients diagnosed with non-adherence by clinicians using Morisky Green Levine Scale (MGL).

Results: Among drug-related medical emergencies, 93 cases were attributed to non-adherence, with a mean patient age of 55.26 years. Seizures emerged as the predominant chief complaint. Antihypertensives were the most commonly prescribed medications, followed by antidiabetics, antiepileptics, and anticoagulants. Notably, a statistically significant association between moderate adherence levels and unemployment was observed. (p<0.001)

Conclusion: The results of our study help identify several characteristics that can be used to identify elders at risk of suffering drug-related or non-adherence-related hospitalizations

Recommended Articles
Loading Image...
Volume-5, Issue-2
Citations
1854 Views
188 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved